| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | General Counsel And Secretary
1 company
Tahl Cindy is a See Remarks at FATE THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 45 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 50,000 | $59.34 | $2,966,852.75 | -6.2% | -29.7% | -83.1% | |
| Oct 1, 2021 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 50,000 | $58.83 | $2,941,461.99 | -11.9% | +1.0% | -62.3% | |
| Jul 1, 2021 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 55,534 | $85.24 | $4,733,743.28 | -3.1% | -36.6% | -73.3% | |
| Apr 1, 2021 | FATE Fate Therapeutics Inc | See Remarks | Sale+OE | 30,000 | $83.81 | $2,514,329.03 | -3.0% | +6.0% | -49.6% | |
| Jan 19, 2021 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 35,000 | $114.76 | $4,016,639.28 | -8.4% | - | - | |
| Jan 11, 2021 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sell | 9,483 | $114.94 | $1,090,021.13 | -1.4% | - | - | |
| Nov 5, 2020 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 70,801 | $50.47 | $3,573,391.76 | -19.0% | - | - | |
| Oct 16, 2020 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 29,199 | $50.25 | $1,467,211.79 | -22.7% | - | - | |
| Oct 1, 2020 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 35,000 | $40.74 | $1,426,065.22 | -9.9% | - | - | |
| Jan 8, 2020 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sell | 5,700 | $20.72 | $118,085.19 | -5.4% | - | - |